Skip to main content
. 2018 Jun 26;2(12):1470–1479. doi: 10.1182/bloodadvances.2018016998

Figure 1.

Figure 1.

TTP to symptomatic myeloma stratified by free light chain ratio and BMPC percentage. (A) Median time to progression was 40 months in FLCr ≥100 compared with 93 months in FLCr <100 (P = .0019). (B) Median time to progression was 31 months in BMPC ≥60 compared with 79 months in BMPC <60 (P = .0006).